HER2-Positive Breast Cancer Treatment Market Insights and Forecast to 2032
24 janv. 2024 10h35 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "HER2-Positive Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. ...
Global Antibody Drug Conjugates Market Poised to Reach $19.8 Billion by 2028, Fueled by Increasing Cancer Prevalence and Clinical Advancements
26 oct. 2023 07h33 HE
|
Research and Markets
Dublin, Oct. 26, 2023 (GLOBE NEWSWIRE) -- The "Global Antibody Drug Conjugates (ADC) Market by Product (Kadcyla, Enhertu, Padcev, Polivy), Linker Type (Cleavable, Non-Cleavable), Payload Type...
Global Antibody Drug Conjugates Market to 2030: Rising Incidences of Cancer Worldwide Bolsters Growth
01 juin 2023 11h53 HE
|
Research and Markets
Dublin, June 01, 2023 (GLOBE NEWSWIRE) -- The "Global Antibody Drug Conjugates Market Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.The Global Antibody Drug...
Asia Pacific Antibody Drug Conjugates Market Report 2022-2027: Featuring Key Players Daiichi Sankyo, Eisai, Takeda Pharmaceutical, Pfizer & Others
04 août 2022 04h48 HE
|
Research and Markets
Dublin, Aug. 04, 2022 (GLOBE NEWSWIRE) -- The "Asia Pacific Antibody Drug Conjugates Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering. The rapidly...
Antibody Drug Conjugates Market to Surpass US$ 11.01 Billion, Globally, by end of 2028, Says Coherent Market Insights (CMI)
15 nov. 2021 08h40 HE
|
CMI
SEATTLE, Nov. 15, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global antibody drug conjugates market is estimated to be valued at US$ 4.29 billion in 2021 and is expected to...
HER2 Targeting Therapies Market Assessment 2021-2030 with Profiles of AstraZeneca, Boehringer Ingelheim, GSK, MacroGenics, Pfizer, Puma Biotechnology, Roche, Seagen, Triumvira Immunologics, Zymeworks
29 sept. 2021 06h13 HE
|
Research and Markets
Dublin, Sept. 29, 2021 (GLOBE NEWSWIRE) -- The "HER2 Targeting Therapies Market by Target Disease Indication, Type of Molecule, Type of Therapy and Route of Administration, Key Geographical Regions:...
Global HER2+ Breast Cancer Market Will Expand to 12.1 Billion in 2030
21 sept. 2021 05h43 HE
|
Research and Markets
Dublin, Sept. 21, 2021 (GLOBE NEWSWIRE) -- The "HER2+ Breast Cancer - Global Drug Forecast and Market Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. Breast cancer is...
Cybrexa Therapeutics Announces Expansion of Its Anticancer Pipeline
09 déc. 2019 08h30 HE
|
Cybrexa Therapeutics
NEW HAVEN, Conn., Dec. 09, 2019 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a biotechnology company developing a new class of cancer therapeutics through its alphalex™ tumor targeting platform, today...